Reactogenicity after vaccine and placebo was minimal and comparable,and no serious adverse events were reported, the study indicates.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3taqlAG
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Covaxin third dose demonstrates long-term safety with no serious adverse events, study
https://ift.tt/eA8V8J
No comments:
Post a Comment